Cigna Group (CI)
SEC filings, insider trading & institutional ownership from EDGAR.
The Cigna Group is a global health company, incorporated in Delaware in 1981 through its predecessor companies. It describes its mission as improving the health and vitality of those it serves by delivering a personalized, transparent and affordable health care experience. As of December 31, 2025, it had approximately 67,700 colleagues, more than 185 million customer relationships in more than 30 markets and jurisdictions, and about 1.7 million relationships with health care providers, clinics and facilities. It pairs pharmacy and medical capabilities to improve affordability, transparency and health outcomes, and has set five areas of focus under its Commitments to Better: easier access to care, better support, better value, accountability and transparency.
The company has two segments. Evernorth Health Services includes the Pharmacy Benefit Services and Specialty and Care Services operating segments. Pharmacy Benefit Services covers pharmacy benefits (retail network administration, benefit design consultation, drug utilization review, formulary and rebate management, medical drug management, group purchasing organization administration, value-based programs and the Evernorth Wholesale Marketplace) and home delivery pharmacy through Express Scripts Pharmacy and the EnGuide Pharmacy focused on GLP-1 customers. Specialty and Care Services includes Accredo specialty pharmacy, CuraScript SD health system services (specialty distribution to providers), and care services such as MD Live virtual care and EviCore benefits management. Cigna Healthcare includes U.S. Healthcare and International Health. U.S. Healthcare offers employer medical plans (Open Access Plus, LocalPlus, HMO and PPO options), consumer-driven products, and ACA-compliant individual and family plans in 11 states. It also offers behavioral health, consumer health engagement, cost containment, dental, pharmacy management and stop-loss solutions. International Health offers medical, dental, pharmacy, vision, life, accidental death and dismemberment, and disability coverage. Other Operations holds run-off and non-strategic businesses, and Corporate holds unallocated amounts. On March 19, 2025, the company sold its Medicare Advantage, Medicare stand-alone prescription drug plan, Medicare supplemental benefits and CareAllies businesses to Health Care Service Corporation.
Evernorth serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored plans, workers' compensation plans, government health programs, providers, clinics and hospitals, including a majority of Cigna Healthcare's clients. Three clients drive significant segment revenue: Centene, Prime Therapeutics and the Department of War's TRICARE program. Cigna Healthcare offers administrative services only and insured funding options to employers, groups and individuals. International Health serves multinational employers, intergovernmental and nongovernmental organizations, and globally mobile individuals.
Operationally, Evernorth dispenses drugs through non-exclusive retail pharmacy networks, home delivery and specialty pharmacies. Express Scripts Pharmacy has 11 licensed pharmacies, including four fulfillment pharmacies in Arizona, Indiana, Missouri and New Jersey. EnGuide Pharmacy has two licensed pharmacies, including a fulfillment pharmacy in Ohio. The specialty pharmacy operation has 35 licensed pharmacies, and CuraScript runs four distribution centers. Pharmaceuticals are bought from manufacturers or authorized wholesalers, with one wholesaler supplying about half of purchases. Competitors include pharmacy benefit managers, retail, home delivery and specialty pharmacies, specialty drug distributors, health plans, third-party administrators, group purchasing organizations, clinical solutions and data analytics companies, and care services providers.
AI-summarized from Item 1 (Business) of the company’s most recent 10-K filing.
Financials
As reported to the SEC via XBRL, no adjustments
| Operating income | $9.2B |
| Diluted EPS | $22.18 |
| Net margin | 2.2% |
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
| Form | Filed | Accession |
|---|---|---|
| 10-Q | Nov 5, 2026 | 0001739940-26-000071EDGAR |
| 8-K | Nov 5, 2026 | 0001140361-26-042030EDGAR |
| 8-K | Oct 10, 2026 | 0001140361-26-039271EDGAR |
| 8-K | Sep 30, 2026 | 0001140361-26-038056EDGAR |
| 4Neville Everett | Sep 8, 2026 | 0001641142-26-000003EDGAR |
| 4Evanko Brian C | Sep 3, 2026 | 0001722909-26-000007EDGAR |
| 4Jones Nicole S | Aug 20, 2026 | 0001492663-26-000003EDGAR |
| 4Jones Nicole S | Aug 6, 2026 | 0001739940-26-000067EDGAR |
Insider trading
From Form 4 filings
| Insider | Date | Type |
|---|---|---|
| Neville Everett | Sep 3, 2026 | Sell |
| Evanko Brian C | Sep 1, 2026 | Grant / award |
| Jones Nicole S | Aug 18, 2026 | Sell |
| Jones Nicole S | Aug 5, 2026 | Option exercise |
| Jones Nicole S | Aug 4, 2026 | Sell |
Top holders
13F & 13D/G • latest quarter
| Holder | Stake | Filed | Value |
|---|---|---|---|
| BlackRock, Inc. | 8.9% | Aug 7, 2026 | $6.46B |
| Vanguard Capital Management | 6.6% | Aug 13, 2026 | $4.76B |
| STATE STREET CORPORATION | 4.8% | Sep 22, 2026 | $3.5B |
| Dodge & Cox | 4.6% | Aug 13, 2026 | $3.36B |
| Massachusetts Financial Services Company | 4.0% | Aug 3, 2026 | $2.9B |
CI's filings are public. The insight is one click away.
Scrutar's AI reads every CI filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a CI filing.
Get an email when CI files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Companies related to CI
Peers identified from CI's own SEC filings.
Data as of Nov 8, 2026Source: SEC EDGAR.